Hello.

Dementia is a disease that causes suffering to many families around the world, and its impact is very deep across individuals, families, and society as a whole.
The exact cause of dementia has not yet been identified,
and existing treatments are burdening many patients and their families due to high costs and side effects.

Redicure was founded in 2021 to solve this serious problem,
and has been continuously striving to create a new breakthrough in the treatment of degenerative neurological diseases.

We are developing an innovative solution called non-drug treatment by combining digital X-ray and AI.

This technology overcomes the limitations of existing treatments and opens the possibility of providing safer and more efficient treatment to patients.

In particular, HeLaXON, which we are developing, is a medical device that provides personalized treatment by combining the multi-mechanism of digital X-ray and AI technology.

We believe that this system can bring about better results in the treatment of degenerative neurological diseases such as dementia through an innovative approach utilizing low-energy, pulsed beams.

Redicure is committed to building a digital X-ray treatment ecosystem,
so that patients with degenerative neurological diseases around the world can receive more efficient and safe treatment.

Our vision is not simply to develop technology, but to substantially improve the quality of life of patients and their caregivers.

We hope that our innovative treatments can bring new hope to patients and their families around the world,

and we ask for your continued interest and support.

Thank you.

Redicure CEO 정원규